Magnetic resonance imaging of Alzheimer's disease

European Radiology

Volumn 17, Issue 2, 2007, Pages 347-362

  Lehéricy, Stéphane ^a,b   Marjanska, Malgorzata ^c   Mesrob, Lilia ^b   Sarazin, Marie ^a   Kinkingnehun, Serge ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Diffusion; MRI; Perfusion; Spectroscopy; Volumetry

Indexed keywords

APOLIPOPROTEIN E4; CREATINE PHOSPHATE; INOSITOL; N ACETYLASPARTIC ACID; SUPERPARAMAGNETIC IRON OXIDE; TRACER;

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN PERFUSION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; EARLY DIAGNOSIS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMAGE ANALYSIS; MORPHOMETRICS; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NEUROPIL THREAD; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONSET AGE; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; RISK FACTOR; SPIN LABELING; VASCULAR DISEASE; VASCULAR LESION; VOLUMETRY;

ALZHEIMER DISEASE; ATROPHY; BRAIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEUROPSYCHOLOGICAL TESTS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846466751     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-006-0341-z     Document Type: Review

References (175)

1. Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52(6):1158-1165
2. Braak H, Braak E (1995) Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 16(3):271-278, discussion 8-84
3. DeCarli C, Kaye JA, Horwitz B, Rapoport SI (1990) Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type. Neurology 40(6):872-883
4. de Leon MJ, George AE, Stylopoulos LA, Smith G, Miller DC (1989) Early marker for Alzheimer's disease: The atrophic hippocampus. Lancet 2(8664):672-673
5. Seab JP, Jagust WJ, Wong ST, Roos MS, Reed BR, Budinger TF (1988) Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 8(2):200-208
6. Meguro K, LeMestric C, Landeau B, Desgranges B, Eustache F, Baron JC (2001) Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: A PET/MRI correlative study. J Neurol Neurosurg Psychiatry 71(3):315-321
7. Scheltens P, Fox N, Barkhof F, De Carli C (2002) Structural magnetic resonance imaging in the practical assessment of dementia: Beyond exclusion. Lancet Neurol 1(1):13-21
8. Wahlund LO, Julin P, Johansson SE, Scheltens P (2000) Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: A comparative study. J Neurol Neurosurg Psychiatry 69(5):630-635
9. Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 42(1):183-188
10. Hampel H, Teipel SJ, Bayer W, Alexander GE, Schwarz R, Schapiro MB, Rapoport SI, Moller HJ (2002) Age transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer's disease. J Neurol Sci 194(1):15-19
11. Kesslak JP, Nalcioglu O, Cotman CW (1991) Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 41(1):51-54
12. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F (1993) Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 50(9):949-954
13. Cuenod CA, Denys A, Michot JL, Jehenson P, Forette F, Kaplan D, Syrota A, Boller F (1993) Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol 50(9):941-945
14. Lehericy S, Baulac M, Chiras J, Pierot L, Martin N, Pillon B, Deweer B, Dubois B, Marsault C (1994) Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. Am J Neuroradiol 15(5):929-937
15. Pitkanen A, Laakso M, Kalviainen R, Partanen K, Vainio P, Lehtovirta M, Riekkinen P, Soininen H (1996) Severity of hippocampal atrophy correlates with the prolongation of MRI T2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease. Neurology 46(6):1724-1730
16. Frisoni GB, Beltramello A, Weiss C, Geroldi C, Bianchetti A, Trabucchi M (1996) Linear measures of atrophy in mild Alzheimer disease. Am J Neuroradiol 17(5):913-923
17. Jack CR Jr, Petersen RC, Xu YC, Waring SC, O'Brien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E (1997) Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 49(3):786-794
18. Laakso MP, Lehtovirta M, Partanen K, Riekkinen PJ, Soininen H (2000) Hippocampus in Alzheimer's disease: A 3-year follow-up MRI study. Biol Psychiatry 47(6):557-561
19. Bobinski M, de Leon MJ, Convit A, De Santi S, Wegiel J, Tarshish CY, Saint Louis LA, Wisniewski HM (1999) MRI of entorhinal cortex in mild Alzheimer's disease. Lancet 353(9146):38-40
20. Du AT, Schuff N, Kramer JH, Ganzer S, Zhu XP, Jagust WJ, Miller BL, Reed BR, Mungas D, Yaffe K, Chui HC, Weiner MW (2004) Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology 62(3):422-427
21. Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, Yaffe K, Kramer JH, Reed B, Norman D, Chui HC, Weiner MW (2001) Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 71(4):441-447
22. Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS (2002) MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 58(8):1188-1196
23. Juottonen K, Laakso MP, Insausti R, Lehtovirta M, Pitkanen A, Partanen K, Soininen H (1998) Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease. Neurobiol Aging 19(1):15-22
24. Frisoni GB, Laakso MP, Beltramello A, Geroldi C, Bianchetti A, Soininen H, Trabucchi M (1999) Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology 52(1):91-100
25. Juottonen K, Laakso MP, Partanen K, Soininen H (1999) Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. Am J Neuroradiol 20(1):139-144
26. Xu Y, Jack CR Jr, O'Brien PC, Kokmen E, Smith GE, Ivnik RJ, Boeve BF, Tangalos RG, Petersen RC (2000) Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 54(9):1760-1767
27. Ashburner J, Friston KJ (2000) Voxel-based morphometry-the methods. Neuroimage 11(6 Pt 1):805-821
28. Baron JC, Chetelat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, Eustache F (2001) In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 14(2):298-309
29. Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O'Brien JT, Scheltens P, McKeith IG, Williams D, Ballard C, Barkhof F (2003) A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 18(4):895-907
30. Garrido GE, Furuie SS, Buchpiguel CA, Bottino CM, Almeida OP, Cid CG, Camargo CH, Castro CC, Glabus MF, Busatto GF (2002) Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: A combined MRI and SPECT study. J Neurol Neurosurg Psychiatry 73(5):508-516
31. Frisoni GB, Testa C, Zorzan A, Sabattoli F, Beltramello A, Soininen H, Laakso MP (2002) Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 73(6):657-664
32. Hirata Y, Matsuda H, Nemoto K, Ohnishi T, Hirao K, Yamashita F, Asada T, Iwabuchi S, Samejima H (2005) Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Lett 382(3):269-274
33. Grossman M, McMillan C, Moore P, Ding L, Glosser G, Work M, Gee J (2004) What's in a name: Voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain 127(Pt 3):628-649
34. Burton EJ, McKeith IG, Burn DJ, Williams ED, JT OB (2004) Cerebral atrophy in Parkinson's disease with and without dementia: A comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127(Pt 4):791-800
35. Busatto GF, Garrido GE, Almeida OP, Castro CC, Camargo CH, Cid CG, Buchpiguel CA, Furuie S, Bottino CM (2003) A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease. Neurobiol Aging 24(2):221-231
36. Frisoni GB, Testa C, Sabattoli F, Beltramello A, Soininen H, Laakso MP (2005) Structural correlates of early and late onset Alzheimer's disease: Voxel based morphometric study. J Neurol Neurosurg Psychiatry 76(1):112-114
37. Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, Crum WR, Rossor MN, Frackowiak RS (2002) Automatic differentiation of anatomical patterns in the human brain: Validation with studies of degenerative dementias. Neuroimage 17(1):29-46
38. Testa C, Laakso MP, Sabattoli F, Rossi R, Beltramello A, Soininen H, Frisoni GB (2004) A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease. J Magn Reson Imaging 19(3):274-282
39. Jack CR Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Tangalos EG, Kokmen E (1998) Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 51(4):993-999
40. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14(1 Pt 1):21-36
41. Thompson PM, Hayashi KM, Sowell ER, Gogtay N, Giedd JN, Rapoport JL, de Zubicaray GI, Janke AL, Rose SE, Semple J, Doddrell DM, Wang Y, van Erp TG, Cannon TD, Toga AW (2004) Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 23 (Suppl 1):S2-S18
42. Thompson PM, Mega MS, Woods RP, Zoumalan CI, Lindshield CJ, Blanton RE, Moussai J, Holmes CJ, Cummings JL, Toga AW (2001) Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex 11(1):1-16
43. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM, Toga AW (2003) Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23(3):994-1005
44. Chen K, Reiman EM, Alexander GE, Bandy D, Renaut R, Crum WR, Fox NC, Rossor MN (2004) An automated algorithm for the computation of brain volume change from sequential MRIs using an iterative principal component analysis and its evaluation for the assessment of whole-brain atrophy rates in patients with probable Alzheimer's disease. Neuroimage 22(1):134-143
45. Carmichael OT, Aizenstein HA, Davis SW, Becker JT, Thompson PM, Meltzer CC, Liu Y (2005) Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage 27(4):979-990
46. Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN (2001) Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358(9277):201-205
47. Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC (2004) Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62(4):591-600
48. Du AT, Schuff N, Zhu XP, Jagust WJ, Miller BL, Reed BR, Kramer JH, Mungas D, Yaffe K, Chui HC, Weiner MW (2003) Atrophy rates of entorhinal cortex in AD and normal aging. Neurology 60(3):481-486
49. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10(2):122-126
50. Lehericy S, Hirsch EC, Cervera-Pierot P, Hersh LB, Bakchine S, Piette F, Duyckaerts C, Hauw JJ, Javoy-Agid F, Agid Y (1993) Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J Comp Neurol 330(1):15-31
51. Sasaki M, Ehara S, Tamakawa Y, Takahashi S, Tohgi H, Sakai A, Mita T (1995) MR anatomy of the substantia innominata and findings in Alzheimer disease: A preliminary report. Am J Neuroradiol 16(10):2001-2007
52. Tanaka Y, Hanyu H, Sakurai H, Takasaki M, Abe K (2003) Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer's disease patients. Dement Geriatr Cogn Disord 16(3):119-125
53. Fox NC, Warrington EK, Rossor MN (1999) Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet 353(9170):2125
54. Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002) Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 99(7):4703-4707
55. Fox NC, Scahill RI, Crum WR, Rossor MN (1999) Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 52(8):1687-1689
56. Bigler ED, Lowry CM, Anderson CV, Johnson SC, Terry J, Steed M (2000) Dementia, quantitative neuroimaging, and apolipoprotein E genotype. Am J Neuroradiol 21(10):1857-1868
57. Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, Kazui H, Mori E (2001) Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 57(8):1461-1466
58. Kaye JA, Swihart T, Howieson D, Dame A, Moore MM, Karnos T, Camicioli R, Ball M, Oken B, Sexton G (1997) Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 48(5):1297-1304
59. Moffat SD, Szekely CA, Zonderman AB, Kabani NJ, Resnick SM (2000) Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology 55(1):134-136
60. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA (1994) Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 44(8):1427-1432
61. Petersen RC, Knopman D, Boeve BF et al (2005) Role of hippocampal volumes in predicting progression to mild cognitive impairment. Neurology 64(6, Suppl 1):A126-A127
62. Linn RT, Wolf PA, Bachman DL, Knoefel JE, Cobb JL, Belanger AJ, Kaplan EF, D'Agostino RB (1995) The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 52(5):485-490
63. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB (1997) Progression to dementia in patients with isolated memory loss. Lancet 349(9054):763-765
64. Soininen HS, Partanen K, Pitkanen A, Vainio P, Hanninen T, Hallikainen M, Koivisto K, Riekkinen PJ Sr (1994) Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: Correlation to visual and verbal memory. Neurology 44(9):1660-1668
65. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52(7):1397-1403
66. De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, Tsui WH, Kandil E, Boppana M, Daisley K, Wang GJ, Schlyer D, Fowler J (2001) Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 22(4):529-539
67. Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J (2002) Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 72(4):491-497
68. Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman BT, Albert MS (2000) Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 47(4):430-439
69. Wolf H, Grunwald M, Kruggel F, Riedel-Heller SG, Angerhofer S, Hojjatoleslami A, Hensel A, Arendt T, Gertz H (2001) Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly. Neurobiol Aging 22(2):177-186
70. Visser PJ, Scheltens P, Verhey FR, Schmand B, Launer LJ, Jolles J, Jonker C (1999) Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol 246(6):477-485
71. Convit A, de Asis J, de Leon MJ, Tarshish CY, De Santi S, Rusinek H (2000) Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging 21(1):19-26
72. Convit A, De Leon MJ, Tarshish C, De Santi S, Tsui W, Rusinek H, George A (1997) Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 18(2):131-138
73. Pennanen C, Testa C, Laakso MP, Hallikainen M, Helkala EL, Hanninen T, Kivipelto M, Kononen M, Nissinen A, Tervo S, Vanhanen M, Vanninen R, Frisoni GB, Soininen H (2005) A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry 76(1):11-14
74. Chetelat G, Landeau B, Eustache F, Mezenge F, Viader F, de la Sayette V, Desgranges B, Baron JC (2005) Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study. Neuroimage 27(4):934-946
75. Karas GB, Scheltens P, Rombouts SA, Visser PJ, van Schijndel RA, Fox NC, Barkhof F (2004) Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 23(2):708-716
76. deToledo-Morrell L, Stoub TR, Bulgakova M, Wilson RS, Bennett DA, Leurgans S, Wuu J, Turner DA (2004) MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging 25(9):1197-1203
77. Dickerson BC, Goncharova I, Sullivan MP, Forchetti C, Wilson RS, Bennett DA, Beckett LA, deToledo-Morrell L (2001) MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 22(5):747-754
78. Jack CR Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Tangalos EG, Kokmen E (2000) Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55(4):484-489
79. Stoub TR, Bulkakova M, Leurgans S, Bennett DA, Fleischman D, Turner DA, deToledo-Morrell L (2005) MRI predictors of risks of incident Alzheimer disease: A longitudinal study. Neuroly 64(9):1520-1524
80. Korf ES, Wahlund LO, Visser PJ, Scheltens P (2004) Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 63(1):94-100
81. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L (2005) The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am 15(4):869-877
82. Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A (1995) Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol Aging 16(4):591-606
83. Insausti R, Juottonen K, Soininen H, Insausti AM, Partanen K, Vainio P, Laakso MP, Pitkanen A (1998) MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. Am J Neuroradiol 19(4):659-671
84. Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M, Hanninen T, Vainio P, Soininen H (1996) Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology 46(3):678-681
85. Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT (2005) Temporal lobe atrophy on MRI in Parkinson disease with dementia: A comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 64(5):861-865
86. Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, Tanimukai S, Hanihara T, Mori E (1998) Medial temporal and whole-brain atrophy in dementia with Lewy bodies: A volumetric MRI study. Neurology 51(2):357-362
87. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT (1999) Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 52(6):1153-1158
88. Barber R, Ballard C, McKeith IG, Gholkar A, O'Brien JT (2000) MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia. Neurology 54(6):1304-1309
89. O'Brien JT, Paling S, Barber R, Williams ED, Ballard C, McKeith IG, Gholkar A, Crum WR, Rossor MN, Fox NC (2001) Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 56(10):1386-1388
90. Ballmaier M, O'Brien JT, Burton EJ, Thompson PM, Rex DE, Narr KL, McKeith IG, DeLuca H, Toga AW (2004) Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: Diagnosis and gender effects. Neuroimage 23(1):325-335
91. Burton EJ, Karas G, Paling SM, Barber R, Williams ED, Ballard CG, McKeith IG, Scheltens P, Barkhof F, O'Brien JT (2002) Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage 17(2):618-630
92. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189-198
93. Petersen RC, Smith GE, Ivnik RJ, Kokmen E, Tangalos EG (1994) Memory function in very early Alzheimer's disease. Neurology 44(5):867-872
94. Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y (1995) Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 45(5):957-962
95. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science 225(4667):1168-1170
96. Deweer B, Lehericy S, Pillon B, Baulac M, Chiras J, Marsault C, Agid Y, Dubois B (1995) Memory disorders in probable Alzheimer's disease: The role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry 58(5):590-597
97. Fama R, Sullivan EV, Shear PK, Marsh L, Yesavage JA, Tinklenberg JR, Lim KO, Pfefferbaum A (1997) Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer disease. Arch Neurol 54(6):719-728
98. Cahn DA, Sullivan EV, Shear PK, Marsh L, Fama R, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A (1998) Structural MRI correlates of recognition memory in Alzheimer's disease. J Int Neuropsychol Soc 4(2):106-114
99. de Toledo-Morrell L, Dickerson B, Sullivan MP, Spanovic C, Wilson R, Bennett DA (2000) Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. Hippocampus 10(2):136-142
100. Petersen RC, Jack CR Jr, Xu YC, Waring SC, O'Brien PC, Smith GE, Ivnik RJ, Tangalos EG, Boeve BF, Kokmen E (2000) Memory and MRI-based hippocampal volumes in aging and AD. Neurology 54(3):581-587
101. Sencakova D, Graff-Radford NR, Willis FB, Lucas JA, Parfitt F, Cha RH, O'Brien PC, Petersen RC, Jack CR Jr (2001) Hippocampal atrophy correlates with clinical features of Alzheimer disease in African Americans. Arch Neurol 58(10):1593-1597
102. Mungas D, Harvey D, Reed BR, Jagust WJ, DeCarli C, Beckett L, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC (2005) Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 65(4):565-571
103. Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, Leschziner G, Rossor AM, Stevens JM, Cipolotti L, Rossor MN (2001) Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol 49(4):433-442
104. Fama R, Sullivan EV, Shear PK, Cahn-Weiner DA, Marsh L, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A (2000) Structural brain correlates of verbal and nonverbal fluency measures in Alzheimer's disease. Neuropsychology 14(1):29-40
105. Thompson PM, Hayashi KM, De Zubicaray GI, Janke AL, Rose SE, Semple J, Hong MS, Herman DH, Gravano D, Doddrell DM, Toga AW (2004) Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 22(4):1754-1766
106. de la Torre JC (2002) Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33(4):1152-1162
107. Skoog I, Kalaria RN, Breteler MM (1999) Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord 13(Suppl 3):S106-S114
108. Hachinski V, Munoz DG (1997) Cerebrovascular pathology in Alzheimer's disease: Cause, effect or epiphenomenon? Ann N Y Acad Sci 826:1-6
109. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM (2001) Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study. Neurology 56(11):1539-1545
110. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1(7):426-436
111. Bastos Leite AJ, Scheltens P, Barkhof F (2004) Pathological aging of the brain: An overview. Top Magn Reson Imaging 15(6):369-389
112. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Joachim C, Litchfield S, Barnetson L, Smith AD (1997) The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 56(2):165-170
113. Goulding JM, Signorini DF, Chatterjee S, Nicoll JA, Stewart J, Morris R, Lammie GA (1999) Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry 67(5):654-657
114. Jagust W, Thisted R, Devous MD Sr, Van Heertum R, Mayberg H, Jobst K, Smith AD, Borys N (2001) SPECT perfusion imaging in the diagnosis of Alzheimer's disease: A clinical-pathologic study. Neurology 56(7):950-956
115. Jobst KA, Barnetson LP, Shepstone BJ (1998) Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: The use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging. Int Psychogeriatr 10(3):271-302
116. Scheltens P, Launer LJ, Barkhof F, Weinstein HC, Jonker C (1997) The diagnostic value of magnetic resonance imaging and technetium 99 m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population. Alzheimer Dis Assoc Disord 11(2):63-70
117. Jagust WJ (1996) Functional imaging patterns in Alzheimer's disease. Relationships to neurobiology. Ann N Y Acad Sci 777:30-36
118. Bartenstein P, Minoshima S, Hirsch C, Buch K, Willoch F, Mosch D, Schad D, Schwaiger M, Kurz A (1997) Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. J Nucl Med 38(7):1095-1101
119. Bozzao A, Floris R, Baviera ME, Apruzzese A, Simonetti G (2001) Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. Am J Neuroradiol 22(6):1030-1036
120. Detre JA, Alsop DC (1999) Perfusion magnetic resonance imaging with continuous arterial spin labeling: Methods and clinical applications in the central nervous system. Eur J Radiol 30(2):115-124
121. Alsop DC, Detre JA (1998) Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 208(2):410-416
122. Alsop DC, Detre JA (1996) Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 16(6):1236-1249
123. Sandson TA, O'Connor M, Sperling RA, Edelman RR, Warach S (1996) Noninvasive perfusion MRI in Alzheimer's disease: A preliminary report. Neurology 47(5):1339-1342
124. Alsop DC, Detre JA, Grossman M (2000) Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 47(1):93-100
125. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: Initial experience. Radiology 234(3):851-859
126. Basser PJ, Pajevic S, Pierpaoli C, Dud-a J, Aldroubi A (2000) In vivo fiber tractography using DT-MRI data. Magn Reson Med 44(4):625-632
127. Mori S, Crain BJ, Chacko VP, van Zijl PC (1999) Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 45(2):265-269
128. Poupon C, Clark CA, Frouin V, Regis J, Bloch I, Le Bihan D, Mangin J (2000) Regularization of diffusion-based direction maps for the tracking of brain white matter fascicles. Neuroimage 12(2):184-195
129. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H (2001) Diffusion tensor imaging: Concepts and applications. J Magn Reson Imaging 13(4):534-546
130. Hanyu H, Sakurai H, Iwamoto T, Takasaki M, Shindo H, Abe K (1998) Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease. J Neurol Sci 156(2):195-200
131. Sandson TA, Felician O, Edelman RR, Warach S (1999) Diffusion-weighted magnetic resonance imaging in Alzheimer's disease. Dement Geriatr Cogn Disord 10(2):166-171
132. Yoshiura T, Mihara F, Tanaka A, Ogomori K, Ohyagi Y, Taniwaki T, Yamada T, Yamasaki T, Ichimiya A, Kinukawa N, Kuwabara Y, Honda H (2003) High b value diffusion-weighted imaging is more sensitive to white matter degeneration in Alzheimer's disease. Neuroimage 20(1):413-419
133. Muller MJ, Greverus D, Dellani PR, Weibrich C, Wille PR, Scheurich A, Stoeter P, Fellgiebel A (2005) Functional implications of hippocampal volume and diffusivity in mild cognitive impairment. Neuroimage 28(4):1033-1042
134. Kantarci K, Jack CR Jr, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC (2001) Mild cognitive impairment and Alzheimer disease: Regional diffusivity of water. Radiology 219(1):101-107
135. Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, Semple J, Doddrell DM (2000) Loss of connectivity in Alzheimer's disease: An evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 69(4):528-530
136. Fellgiebel A, Muller MJ, Wille P, Dellani PR, Scheurich A, Schmidt LG, Stoeter P (2005) Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment. Neurobiol Aging 26(8):1193-1198
137. Sugihara S, Kinoshita T, Matsusue E, Fujii S, Ogawa T (2004) Usefulness of diffusion tensor imaging of white matter in Alzheimer disease and vascular dementia. Acta Radiol 45(6):658-663
138. Takahashi S, Yonezawa H, Takahashi J, Kudo M, Inoue T, Tohgi H (2002) Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging. Neurosci Lett 332(1):45-48
139. Kalus P, Slotboom J, Gallinat J, Mahlberg R, Cattapan-Ludewig K, Wiest R, Nyffeler T, Buri C, Federspiel A, Kunz D, Schroth G, Kiefer C (2005) Examining the gateway to the limbic system with diffusion tensor imaging: The perforant pathway in dementia. Neuroimage
140. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, O'Brien PC, Shiung MM, Smith GE, Ivnik RJ, Tangalos EG, Jack CR Jr (2005) DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64(5):902-904
141. Medina D, Detoledo-Morrell L, Urresta F, Gabrieli JD, Moseley M, Fleischman D, Bennett DA, Leurgans S, Turner DA, Stebbins GT (2005) White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging
142. Kaufer DI, Miller BL, Itti L, Fairbanks LA, Li J, Fishman J, Kushi J, Cummings JL (1997) Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease. Neurology 48(4):978-985
143. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Hayashi T, Oyanagi C, Konishi J, Shio H (2000) Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease. J Neurol Neurosurg Psychiatry 69(5):623-629
144. Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Tan J (1998) In vivo MR spectroscopy of human dementia. Neuroimaging Clin N Am 8(4):809-822
145. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD (1993) Alzheimer disease: Depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 187(2):433-437
146. Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, Ross BD (1995) Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 195(1):65-72
147. Moats RA, Ernst T, Shonk TK, Ross BD (1994) Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 32(1):110-115
148. Jessen F, Block W, Traber F, Keller E, Flacke S, Papassotiropoulos A, Lamerichs R, Heun R, Schild HH (2000) Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 55(5):684-688
149. Jessen F, Traeber F, Freymann N, Maier W, Schild HH, Heun R, Block W (2005) A comparative study of the different N-acetylaspartate measures
150. Firbank MJ, Harrison RM, O'Brien JT (2002) A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Dement Geriatr Cogn Disord 14(2):64-76
151. Adalsteinsson E, Sullivan EV, Kleinhans N, Spielman DM, Pfefferbaum A (2000) Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet 355(9216):1696-1697
152. Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, Norman D, Jagust W, Kramer JH, Mastrianni JA, Fein G, Weiner MW (1997) Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology 49(6):1513-1521
153. Heun R, Schlegel S, Graf-Morgenstern M, Tintera J, Gawehn J, Stoeter P (1997) Proton magnetic resonance spectroscopy in dementia of Alzheimer type. Int J Geriatr Psychiatry 12(3):349-358
154. Sijens PE, den Heijer T, Origgi D, Vermeer SE, Breteler MM, Hofman A, Oudkerk M (2003) Brain changes with aging: MR spectroscopy at supraventricular plane shows differences between women and men. Radiology 226(3):889-896
155. den Heijer T, Sijens PE, Prins ND, Hofman A, Koudstaal PJ, Oudkerk M, Breteler MM (2006) MR spectroscopy of brain white matter in the prediction of dementia. Neurology 66(4):540-544
156. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, Ferman TJ, Tangalos EG, Jack CR Jr (2004) 1 H MR spectroscopy in common dementias. Neurology 63(8):1393-1398
157. Kantarci K, Reynolds G, Petersen RC, Boeve BF, Knopman DS, Edland SD, Smith GE, Ivnik RJ, Tangalos EG, Jack CR Jr (2003) Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. Am J Neuroradiol 24(5):843-849
158. Kantarci K, Jack CR Jr, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1 H MRS study. Neurology 55(2):210-217
159. Valenzuela MJ, Sachdev P (2001) Magnetic resonance spectroscopy in AD. Neurology 56(5):592-598
160. Antuono PG, Jones JL, Wang Y, Li SJ (2001) Decreased glutamate+glutamine in Alzheimer's disease detected in 2vivo with 1 H-MRS at 0.5 T. Neurology 56(6):737-742
161. Hattori N, Abe K, Sakoda S, Sawada T (2002) Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease. Neuroreport 13(1):183-186
162. Sijens PE, den Heijer T, de Leeuw FE, de Groot JC, Achten E, Heijboer RJ, Hofman A, Breteler MM, Oudkerk M (2001) MR spectroscopy detection of lactate and lipid signals in the brains of healthy elderly people. Eur Radiol 11(8):1495-1501
163. Pugliese M, Carrasco JL, Andrade C, Mas E, Mascort J, Mahy N (2005) Severe cognitive impairment correlates with higher cerebrospinal fluid levels of lactate and pyruvate in a canine model of senile dementia. Prog Neuropsychopharmacol Biol Psychiatry 29(4):603-610
164. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55(3):306-319
165. Sair HI, Doraiswamy PM, Petrella JR (2004) In vivo amyloid imaging in Alzheimer's disease. Neuroradiology 46(2):93-104
166. Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, Read S, Satyamurthy N, Petric A, Huang SC, Barrio JR (2002) Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 10(1):24-35
167. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA (1999) Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc Natl Acad Sci USA 96(24):14079-14084
168. Dhenain M, Privat N, Duyckaerts C, Jacobs RE (2002) Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images. NMR Biomed 15(3):197-203
169. Poduslo JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, Borowski BJ, Jack CR Jr (2002) Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis 11(2):315-329
170. Wadghiri YZ, Sigurdsson EM, Wisniewski T, Turnbull DH (2005) Magnetic resonance imaging of amyloid plaques in transgenic mice. Methods Mol Biol 299:365-379
171. Helpern JA, Lee SP, Falangola MF, Dyakin VV, Bogart A, Ardekani B, Duff K, Branch C, Wisniewski T, de Leon MJ, Wolf O, O'Shea J, Nixon RA (2004) MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn Reson Med 51(4):794-798
172. Zhang J, Yarowsky P, Gordon MN, Di Carlo G, Munireddy S, van Zijl PC, Mori S (2004) Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging. Magn Reson Med 51(3):452-457
173. Jack CR Jr, Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, Adriany G, Grohn OH, Grimm R, Poduslo JF (2004) In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 52(6):1263-1271
174. Jack CR Jr, Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Adriany G, Poduslo JF (2005) In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J Neurosci 25(43):10041-10048
175. Higuchi M, Iwata N, Matsuba Y, Sato K, Sasamoto K, Saido TC (2005) 19F and 1 H MRI detection of amyloid beta plaques in vivo. Nat Neurosci 8(4):527-533